Outcomes for PTCL: which pathway to success?-Reference-Cited by-同舟云学术

Outcomes for PTCL: which pathway to success?

Published:2021-05-13 Issue:19 Volume:137 Page:2570-2571
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Vose Julie M.¹^ORCID

Affiliation:

1. University of Nebraska Medical Center

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/137/19/2570/1807106/bloodbld2020009850c.pdf

Reference9 articles.

1. A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL;Schmitz;Blood,2021

2. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group;Schmitz;Blood,2010

3. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial [published correction appears in Lancet. 2019;393(10168):228];Horwitz;Lancet,2019

4. An exploratory analysis of brentuximab vedotin plus CHP (A + CHP) in the frontline treatment of patients with CD30+ peripheral T-cell lymphomas (ECHELON-2): impact of consolidative stem cell transplant [abstract];Savage;Blood,2019

5. Phase I/II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T cell non-Hodgkin lymphoma: Phase I results from the T-cell consortium;Lunning;Hematol Oncol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma;Blood Advances;2024-09-24

2. A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma;Blood;2023-08-17

3. An Unusual Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma;Case Reports in Hematology;2022-06-09